| 000 | 02131cam a2200349 a 4500 | ||
|---|---|---|---|
| 003 | EG-GiCUC | ||
| 005 | 20250223030552.0 | ||
| 008 | 120220s2011 ua d f m 000 0 eng d | ||
| 040 |
_aEG-GiCUC _beng _cEG-GiCUC |
||
| 041 | 0 | _aeng | |
| 049 | _aDeposite | ||
| 097 | _aM.Sc | ||
| 099 | _aCai01.11.15.M.Sc.2011.Ma.L | ||
| 100 | 0 | _aMahmoud Mohamed Ahmed Zaki | |
| 245 | 1 | 0 |
_aLow molecular weight heparin versus unfractionated heparin in pregnant women with recurrent abortion associated with antiphospholipid syndrome / _cMahmoud Mohamed Ahmed Zaki ; Supervised Abdelmegeed Ali Abdelmegeed , Ahmed Mohamed Ahmed , Usama Mohamed Fikry Ragai Fouda |
| 246 | 1 | 5 | _aمقارنة بين الهيبارين قليل الوزن الجزيئى والهيبارين غير المجزء فى علاج النساء الحوامل المصابات بالاجهاض المتكرر الناتج عن متلازمة مضاد الدهون الفوسفاتيه |
| 260 |
_aCairo : _bMahmoud Mohamed Ahmed Zaki , _c2011 |
||
| 300 |
_a99 P. : _bcharts ; _c25cm |
||
| 502 | _aThesis (M.Sc.) - Cairo University - Faculty of Medicine - Department of Gynecology and Obstetrics | ||
| 520 | _aThe aim of this study is to compare the efficacy and safety of the combination of UFH and LDA with that of LMWH and LDA in the management of pregnant women with recurrent pregnancy loss secondary to APS. LMWH plus LDA was successfully used as an alternative to UFH plus LDA in the management of recurrent abortion secondary to APS. The results highlight the need for a larger randomized controlled trial to determine whether LMWH plus LDA should be the treatment of choice for recurrent abortion secondary to APS | ||
| 530 | _aIssued also as CD | ||
| 653 | 4 | _aAntiphospholipid syndrome | |
| 653 | 4 | _aHeparin versus | |
| 653 | 4 | _aPregnant women | |
| 700 | 0 |
_aAbdelmegeed Ali Abdelmegeed , _eSupervisor |
|
| 700 | 0 |
_aAhmed Mohamed Ahmed , _eSupervisor |
|
| 700 | 0 |
_aUsama Mohamed Fikry Ragai Fouda , _eSupervisor |
|
| 856 | _uhttp://172.23.153.220/th.pdf | ||
| 905 |
_aNazla _eRevisor |
||
| 905 |
_aSoheir _eCataloger |
||
| 942 |
_2ddc _cTH |
||
| 999 |
_c37460 _d37460 |
||